Cargando…
Placental transporter‐mediated drug interactions and offspring congenital anomalies
AIMS: P‐glycoprotein (P‐gp) and breast cancer resistance protein (BCRP) are efflux transporters expressed in the placenta, limiting their substrates from reaching the foetus. Our aim was to investigate if concomitant prenatal exposure to several substrates or inhibitors of these transporters increas...
Autores principales: | Ellfolk, Maria, Tornio, Aleksi, Niemi, Mikko, Leinonen, Maarit K., Lahesmaa‐Korpinen, Anna‐Maria, Malm, Heli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7163376/ https://www.ncbi.nlm.nih.gov/pubmed/31823387 http://dx.doi.org/10.1111/bcp.14191 |
Ejemplares similares
-
Second-generation antipsychotic use during pregnancy and risk of congenital malformations
por: Ellfolk, Maria, et al.
Publicado: (2021) -
Clinical Studies on Drug–Drug Interactions Involving Metabolism and Transport: Methodology, Pitfalls, and Interpretation
por: Tornio, Aleksi, et al.
Publicado: (2019) -
Pharmacogenomics of celiprolol – evidence for a role of P‐glycoprotein and organic anion transporting polypeptide 1A2 in celiprolol pharmacokinetics
por: Hirvensalo, Päivi, et al.
Publicado: (2021) -
Itraconazole Increases Ibrutinib Exposure 10‐Fold and Reduces Interindividual Variation—A Potentially Beneficial Drug‐Drug Interaction
por: Tapaninen, Tuija, et al.
Publicado: (2019) -
Maternal use of drug substrates of placental transporters and the effect of transporter-mediated drug interactions on the risk of congenital anomalies
por: Daud, Aizati N. A., et al.
Publicado: (2017)